Genoptix

Handshake business deal executives

MedTech

NeoGenomics to acquire Genoptix in near $140M deal

NeoGenomics has moved to acquire clinical oncology laboratory Genoptix for $125 million in cash plus 1 million shares of stock.

Conor Hale Oct 26, 2018 10:35am

handshake

Genoptix buys sinking cancer test firm Rosetta for $10M

Dec 18, 2017 7:12am

contract

Aerie raids Alcon again, returning this time with an R&D VP

Sep 19, 2017 9:32am